SKIN 10-Q Quarterly Report March 31, 2022 | Alphaminr
ALPHAMINR

SKIN 10-Q Quarter ended March 31, 2022

Balance Sheet
Cash Flow
Income Statement
Debt
CIK: 1818093
Filing Type: 10-Q/A
Report Date: 2022-03-31
Download URL: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000196/skin-20220331.htm
]]>
TABLE OF CONTENTS
Part I Financial InformationItem 1. Financial StatementsNote 1 Description Of BusinessNote 2 Summary Of Significant Accounting PoliciesNote 3 Business CombinationsNote 4 Revenue RecognitionNote 5 Balance Sheet ComponentsNote 6 LeasesNote 7 Fair Value MeasurementsNote 8 Property and Equipment, NetNote 9 Goodwill and Intangible Assets, NetNote 10 Long-term DebtNote 11 Income TaxesNote 12 Equity-based CompensationNote 13 Commitments and ContingenciesNote 14 ConcentrationsNote 15 Related-party TransactionsNote 16 - Stockholders DeficitNote 17 - Segment ReportingNote 18 Net Income (loss) Attributable To Common ShareholdersNote 19 Subsequent EventsItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits

Exhibits

2.1 Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Healthcare Acquisition Corp., Hydrate Merger Sub I, Inc., Hydrate Merger Sub II, LLC, LCP Edge Intermediate, Inc. and LCP Edge Holdco, LLC, in its capacity as the Stockholders Representative 8-K 001-39565 2.1 December 9, 2020 3.1 Second Amended and Restated Certificate of Incorporation of The Beauty Health Company 8-K 001-39565 3.1 May 10, 2021 3.2 Amended and Restated Bylaws of The Beauty Health Company 8-K 001-39565 3.2 May 10, 2021 4.1 Indenture, dated as of September 14, 2021, between The Beauty Health Company and U.S. Bank National Association, as trustee 8-K 001-39565 4.1 September 14, 2021 4.2 Form of certificate representing the 1.25% Convertible Senior Notes due 2026 (included as Exhibit A to Exhibit 4.1) 8-K 001-39565 4.2 September 14, 2021 10.1 Form of Confirmation for Capped Call Transactions 8-K 001-39565 10.1 September 14, 2021 10.2# Employment Agreement, dates as of January 20, 2022, between Andrew Stanleick, Edge Systems LLC d/b/a The HydraFacial Company and The Beauty Health Company 8-K 001-39565 10.1 January 20, 2022 31.1* Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2* Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002